Literature DB >> 15933064

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma.

Mattias Berglund, Ulf Thunberg, Göran Roos, Richard Rosenquist, Gunilla Enblad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15933064     DOI： 10.1182/blood-2004-12-4814

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.

Authors:  Zhi-Ming Dai; Ai-Li He; Wang-Gang Zhang; Jie Liu; Xing-Mei Cao; Yin-Xia Chen; Xiao-Rong Ma; Wan-Hong Zhao; Zhi-Jun Dai
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.

Authors:  Thomas M Habermann; Sophia S Wang; Matthew J Maurer; Lindsay M Morton; Charles F Lynch; Stephen M Ansell; Patricia Hartge; Richard K Severson; Nathaniel Rothman; Scott Davis; Susan M Geyer; Wendy Cozen; Stephen J Chanock; James R Cerhan
Journal:  Blood       Date:  2008-07-16       Impact factor: 22.113

3.  Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.

Authors:  Hervé Ghesquières; Matthew J Maurer; Olivier Casasnovas; Stephen M Ansell; Beth R Larrabee; Eva Lech-Maranda; Anne J Novak; Anne-Laure Borrel; Susan L Slager; Pauline Brice; Cristine Allmer; Annie Brion; Steven C Ziesmer; Franck Morschhauser; Thomas M Habermann; Isabelle Gaillard; Brian K Link; Aspasia Stamatoullas; Christophe Fermé; Ahmet Dogan; William R Macon; Josée Audouin; James R Cerhan; Gilles Salles
Journal:  Cytokine       Date:  2013-09-03       Impact factor: 3.861

Review 4.  Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.

Authors:  Yan Zhang; Zu-Guang Xia; Jin-Hong Zhu; Min-Bin Chen; Tong-Min Wang; Wen-Xiang Shen; Jing He
Journal:  Mol Genet Genomics       Date:  2015-05-15       Impact factor: 3.291

5.  Risk Factors of Non-Hodgkin Lymphoma.

Authors:  Yawei Zhang; Ying Dai; Tongzhang Zheng; Shuangge Ma
Journal:  Expert Opin Med Diagn       Date:  2011-11-01

6.  Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.

Authors:  Nils Schoof; Jeremy Franklin; Robert Fürst; Thomas Zander; Frederike von Bonin; Frederic Peyrade; Lorenz Trümper; Volker Diehl; Andreas Engert; Dieter Kube; Daniel Re
Journal:  Oncologist       Date:  2013-01-08

7.  Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas.

Authors:  Olivera Tarabar; Bojana Cikota-Aleksić; Ljiljana Tukić; Nenad Milanović; Aleksandar Aleksić; Zvonko Magić
Journal:  Int J Clin Oncol       Date:  2013-03-27       Impact factor: 3.402

8.  Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.

Authors:  Carolina Minnicelli; Mário H M Barros; Claudete E Klumb; Sérgio O Romano; Ilana R Zalcberg; Rocio Hassan
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

9.  Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.

Authors:  Hala Aly Abdel Rahman; Mervat Mamdooh Khorshied; Ola Mohamed Reda Khorshid; Heba Mahmoud Mourad
Journal:  Turk J Haematol       Date:  2017-07-17       Impact factor: 1.831

10.  Interleukin-10 and tumor necrosis factor-alpha polymorphisms in vascular access failure in patients on hemodialysis: preliminary data in Korea.

Authors:  Su Ah Sung; Gang Jee Ko; Sang Kyung Jo; Won Yong Cho; Hyoung Kyu Kim; So Young Lee
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.